Order Article Reprints

Knitter S, Duwe G, Beierle AS, Pesthy S, Ritschl PV, Hillebrandt KH, Arnold A, Malinka T, Modest DP, Bahra M, et al. Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null Mice. Cancers. 2022; 14(23):5992. https://doi.org/10.3390/cancers14235992

Knitter, Sebastian, Gregor Duwe, Anika Sophie Beierle, Sina Pesthy, Paul Viktor Ritschl, Karl Herbert Hillebrandt, Alexander Arnold, Thomas Malinka, Dominik Paul Modest, Marcus Bahra, and et al. 2022. "Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null Mice" Cancers 14, no. 23: 5992. https://doi.org/10.3390/cancers14235992

Knitter, S., Duwe, G., Beierle, A. S., Pesthy, S., Ritschl, P. V., Hillebrandt, K. H., Arnold, A., Malinka, T., Modest, D. P., Bahra, M., Pratschke, J., Sauer, I. M., Schmelzle, M., & Andreou, A. (2022). Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null Mice. Cancers, 14(23), 5992. https://doi.org/10.3390/cancers14235992